Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncol. 2018 Dec 1;4(12):1784-1785. doi: 10.1001/jamaoncol.2018.4625.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes*

Substances

  • Immunologic Factors
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen